Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/12 (2006.01) A61K 31/505 (2006.01) A61K 31/506 (2006.01) A61P 29/00 (2006.01) C07D 239/42 (2006.01) C07D 401/12 (2006.01)

Patent

CA 2456127

The invention provides compounds of formula I or a pharmaceutically acceptable salt or ester thereof (I), wherein the symbols have meaning as defined, which are inhibitors of cathepsin K and find use pharmaceutically for treatment of diseases and medical conditions in which cathepsin K is implicated, e.g. various disorders including inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors.

La présente invention concerne des composés de formule (I) ou un sel ou ester de ceux-ci, acceptable d'un point de vue pharmaceutique. Dans la formule (I), les symboles ont les correspondances indiquées. Lesdits composés sont des inhibiteurs de cathepsine K et trouvent des applications pharmaceutiques dans le traitement de troubles et d'états pathologiques dans lesquels la cathepsine K est impliquée, par ex. différents troubles comprenant l'inflammation, l'arthrite rhumatoïde, l'ostéoarthrite, l'ostéoporose et les tumeurs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1670220

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.